Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates
  2. de Castro, Isabela Silva; Gorini, Giacomo; Mason, Rosemarie; Gorman, Jason; Bissa, Massimiliano; Rahman, Mohammad A.; Arakelyan, Anush; Kalisz, Irene; Whitney, Stephen; Becerra-Flores, Manuel; Ni, Eric; Peachman, Kristina; Trinh, Hung; Read, Michael; Liu, Mei-Hue; Van Ryk, Donald; Paquin-Proulx, Dominic; Shubin, Zhanna; Tuyishime, Marina; Peele, Jennifer; Ahmadi, Mohammed S.; Verardi, Raffaello; Hill, Juliane; Beddall, Margaret; Nguyen, Richard; Stamos, James D.; Fujikawa, Dai; Min, Susie; Schifanella, Luca; Vaccari, Monica; Galli, Veronica; Doster, Melvin N.; Liyanage, Namal P. M.; Sarkis, Sarkis; Caccuri, Francesca; LaBranche, Celia; Montefiori, David C.; Tomaras, Georgia D.; Shen, Xiaoying; Rosati,Margherita; Felber, Barbara K.; Pavlakis,George; Venzon, David J.; Magnanelli, William; Breed, Matthew; Kramer, Josh; Keele, Brandon F.; Eller, Michael A.; Cicala, Claudia; Arthos, James; Ferrari, Guido; Margolis, Leonid; Robert-Guroff, Marjorie; Kwong, Peter D.; Roederer, Mario; Rao, Mangala; Cardozo, Timothy J.; Franchini, Genoveffa
  3. iScience. 2021, Feb 19; 24(2):
  1. 2.   Interaction between the HTLV-I envelope and cellular proteins: impact on virus infection and restriction
  2. Ilinskaya, A.; Heidecker, G.; Jones, K.
  3. Future Medicinal Chemistry. 2010, Nov; 2(11): 1651-1668.
  1. 3.   Role of the HIV gp120 conserved domain 5 in processing and viral entry
  2. Sen, J.; Jacobs, A.; Caffrey, M.
  3. Biochemistry. 2008 47(30): 7788-7795.
  1. 4.   Glycosylation of gp41 of Simian Immunodeficiency Virus Shields Epitopes That Can Be Targets for Neutralizing Antibodies
  2. Yuste, E.; Bixby, J.; Lifson, J.; Sato, S.; Johnson, W.; Desrosiers, R.
  3. Journal of Virology. 2008 82(24): 12472-12486.
  1. 5.   Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion
  2. Garg, H.; Joshi, A.; Freed, E. O.; Blumenthal, R.
  3. Journal of Biological Chemistry. 2007, Jun; 282(23): 16899-16906.
  1. 6.   Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion
  2. Rawat, S. S.; Viard, M.; Gallo, S. A.; Blumenthal, R.; Puri, A.
  3. Glycoconjugate Journal. 2006, MAY; 23(3-4): 189-197.
  1. 7.   A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection
  2. Lund, N.; Branch, D. R.; Mylvaganam, M.; Chark, D.; Ma, X. Z.; Sakac, D.; Binnington, B.; Fantini, J.; Puri, Z.; Blumenthal, R.; Lingwood, C.
  3. Aids. 2006, Feb; 20(3): 333-343.
  1. 9.   Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus
  2. Yuste, E.; Johnson, W.; Pavlakis, G. N.; Desrosiers, R. C.
  3. Journal of Virology. 2005, OCT; 79(19): 12455-12463.
  1. 10.   Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion
  2. Rawat, S. S.; Eaton, J.; Gallo, S. A.; Martin, T. D.; Ablan, S.; Ratnayake, S.; Viard, M.; KewalRamani, V. N.; Wang, J. M.; Blumenthal, R.; Puri, A.
  3. Virology. 2004 318(1): 55-65.
  1. 11.   The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively
  2. Shnaper, S.; Sackett, K.; Gallo, S. A.; Blumenthal, R.; Shai, Y.
  3. Journal of Biological Chemistry. 2004 279(18): 18526-18534.
  1. 12.   C-terminal octylation rescues an inactive T20 mutant - Implications for the mechanism of HIV/simian immunodeficiency virus-induced membrane fusion
  2. Peisajovich, S. G.; Gallo, S. A.; Blumenthal, R.; Shai, Y.
  3. Journal of Biological Chemistry. 2003 278(23): 21012-21017.
  1. 13.   The HIV Env-mediated fusion reaction
  2. Gallo, S. A.; Finnegan, C. M.; Viard, M.; Raviv, Y.; Dimitrov, A.; Rawat, S. S.; Puri, A.; Durell, S.; Blumenthal, R.
  3. Biochimica Et Biophysica Acta-Biomembranes. 2003 1614(1): 36-50.
  1. 14.   Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
  2. Robinson, H. L.; Montefiori, D. C.; Johnson, R. P.; Manson, K. H.; Kalish, M. L.; Lifson, J. D.; Rizvi, T. A.; Lu, S.; Hu, S. L.; Mazzara, G. P.; Panicali, D. L.; Herndon, J. G.; Glickman, R.; Candido, M. A.; Lydy, S. L.; Wyand, M. S.; McClure, H. M.
  3. Nature Medicine. 1999 5(5): 526-534.
  1. 15.   Glycosylation Affects Both the Three-Dimensional Structure and Antibody Binding Properties of the Hiv-1(Iiib) Gp120 Peptide Rp135
  2. Huang, X. L.; Barchi, J. J.; Lung, E. D. T.; Roller, P. P.; Nara, P. L.; Muschik, J.; Garrity, R. R.
  3. Biochemistry. 1997 36(36): 10846-10856.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel